Myelin basic protein and neurofilament as biomarkers of treatment response in a Phase II add-on trial of rituximab for relapsing multiple sclerosis
Journal article published in 2012 by
Enrique Alvarez 
,
Laura Piccio,
Nhial Tutlam,
Robert J. Mikesell,
Neville S. Rapp,
Samantha Lancia,
Becky J. Parks,
Robert J. Naismith,
Anne H. Cross
,
Laura Piccio,
Nhial Tutlam,
Robert J. Mikesell,
Neville S. Rapp,
Samantha Lancia,
Becky J. Parks,
Robert J. Naismith,
Anne H. Cross
